We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+4.08%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$1.22T
AUM Growth
+$35.8B
Cap. Flow
+$1.4B
Cap. Flow %
0.11%
Top 10 Hldgs %
24.28%
Holding
7,917
New
549
Increased
2,512
Reduced
3,286
Closed
579

Sector Composition

Rank Sector Weight
1 Technology 24.03%
2 Healthcare 9.24%
3 Consumer Discretionary 8.79%
4 Financials 8.61%
5 Industrials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LONA
6451
LeonaBio Inc
LONA
$73.9M
$379 ﹤0.01%
14
-740
-98% -$17.5K
QNRX
6452
Quoin Pharmaceuticals
QNRX
$11.8M
$375 ﹤0.01%
18
THCH icon
6453
TH International
THCH
$54.5M
$364 ﹤0.01%
97
-93
-49% -$480
TECX
6454
Tectonic Therapeutic
TECX
$720M
$362 ﹤0.01%
22
-2
-8% -$32
PNF
6455
DELISTED
PIMCO New York Municipal Income Fund
PNF
$360 ﹤0.01%
+46
New +$354
PPBT
6456
Purple Biotech
PPBT
$2.41M
$356 ﹤0.01%
4
PRST
6457
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$354 ﹤0.01%
5,054
-2,118
-30% -$309
VHC icon
6458
VirnetX Holding Corp
VHC
$65.8M
$353 ﹤0.01%
52
+1
+2% +$5
ACHR icon
6459
PUT
Archer Aviation
ACHR
$4.84B
$352 ﹤0.01%
+100
New +$371
QNCX icon
6460
Quince Therapeutics
QNCX
$31.8M
$352 ﹤0.01%
2
YARW
6461
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
$347 ﹤0.01%
4
+1
+33% +$125
EXG icon
6462
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$3.09B
$346 ﹤0.01%
41
IIGD icon
6463
Invesco Investment Grade Defensive ETF
IIGD
$26.8M
$344 ﹤0.01%
14
-70
-83% -$1.67K
SYLD icon
6464
Cambria Shareholder Yield ETF
SYLD
$1.02B
$344 ﹤0.01%
5
-87
-95% -$6.08K
CTMX icon
6465
CytomX Therapeutics
CTMX
$760M
$343 ﹤0.01%
281
SABS icon
6466
SAB Biotherapeutics
SABS
$346M
$329 ﹤0.01%
106
+2
+2% +$7
ENLV icon
6467
Enlivex Ltd
ENLV
$31M
$328 ﹤0.01%
15
-462
-97% -$12.3K
SSKN
6468
DELISTED
Strata Skin Sciences
SSKN
$322 ﹤0.01%
105
+50
+91% +$203
PBJ icon
6469
Invesco Food & Beverage ETF
PBJ
$107M
$319 ﹤0.01%
7
BETR icon
6470
Better Home & Finance Holding
BETR
$21.3M
$310 ﹤0.01%
+14
New +$282
SPRO icon
6471
Spero Therapeutics
SPRO
$68.9M
$307 ﹤0.01%
236
GURU icon
6472
Global X Guru Index ETF
GURU
$64M
$302 ﹤0.01%
7
-5
-42% -$213
CVM icon
6473
CEL-SCI Corp
CVM
$25.9M
$300 ﹤0.01%
9
SEEL
6474
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$300 ﹤0.01%
31
-1
-3% -$34
OBE
6475
Obsidian Energy
OBE
$695M
$298 ﹤0.01%
42

Similar funds

JP Morgan Chase's Q2 2024 Portfolio in Review

As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.

JP Morgan Chase's Q2 2024 filing shows 549 new, 2,512 increased, 3,286 reduced and 579 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
  • JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
  • JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
  • JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
  • JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
  • JP Morgan Chase opened 549 new positions and closed 579 in Q2 2024.
  • JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.

Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.